Peri-operative blood-loss after total hip arthroplasty can be significantly reduced with topical application of epsilon-aminocaproic acid

International Orthopaedics

Volumn 40, Issue 10, 2016, Pages 2019-2023

  Sucher, Mark G ^a   Giordani, Mauro ^a   Figoni, Andrew ^a   Nedopil, Alexander J ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Blood loss; Epsilon aminocaproic acid; Total hip arthroplasty

Indexed keywords

AMINOCAPROIC ACID; ANTIFIBRINOLYTIC AGENT;

ADULT; ARTICLE; CONTROLLED STUDY; COST CONTROL; DRUG COST; ERYTHROCYTE CONCENTRATE; ERYTHROCYTE TRANSFUSION; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; OPERATIVE BLOOD LOSS; OSTEOARTHRITIS; POSTOPERATIVE ANALGESIA; PRIORITY JOURNAL; RETROSPECTIVE STUDY; TOPICAL TREATMENT; TOTAL HIP PROSTHESIS; AGED; BLOOD LOSS, SURGICAL; BLOOD TRANSFUSION; HIP REPLACEMENT; PROCEDURES; THROMBOEMBOLISM; TOPICAL DRUG ADMINISTRATION;

ADMINISTRATION, TOPICAL; AGED; AMINOCAPROIC ACID; ANTIFIBRINOLYTIC AGENTS; ARTHROPLASTY, REPLACEMENT, HIP; BLOOD LOSS, SURGICAL; BLOOD TRANSFUSION; FEMALE; HUMANS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; THROMBOEMBOLISM;

EID: 84953393595     PISSN: 03412695     EISSN: 14325195     Source Type: Journal    
DOI: 10.1007/s00264-015-3103-1     Document Type: Article

References (29)

1. Rosencher N, Kerkkamp HE, Macheras G, Munuera LM, Menichella G, Barton DM, Cremers S, Abraham IL, Investigation O (2003) Orthopedic surgery transfusion hemoglobin european overview (OSTHEO) study: blood management in elective knee and hip arthroplasty in Europe. Transfusion 43(4):459–469
2. Johansson T, Pettersson LG, Lisander B (2005) Tranexamic acid in total hip arthroplasty saves blood and money: a randomized, double-blind study in 100 patients. Acta Orthop 76(3):314–319
3. Risberg B (1985) The response of the fibrinolytic system in trauma. Acta Chir Scand Suppl 522:245–271
4. Chapin JC, Hajjar KA (2015) Fibrinolysis and the control of blood coagulation. Blood Rev 29(1):17–24. doi:10.1016/j.blre.2014.09.003
5. Morais S, Ortega-Andreu M, Rodriguez-Merchan EC, Padilla-Eguiluz NG, Perez-Chrzanowska H, Figueredo-Zalve R, Gomez-Barrena E (2014) Blood transfusion after primary total knee arthroplasty can be significantly minimised through a multimodal blood-loss prevention approach. Int Orthop 38(2):347–354. doi:10.1007/s00264-013-2188-7
6. Ishida K, Tsumura N, Kitagawa A, Hamamura S, Fukuda K, Dogaki Y, Kubo S, Matsumoto T, Matsushita T, Chin T, Iguchi T, Kurosaka M, Kuroda R (2011) Intra-articular injection of tranexamic acid reduces not only blood loss but also knee joint swelling after total knee arthroplasty. Int Orthop 35(11):1639–1645. doi:10.1007/s00264-010-1205-3
7. Iwai T, Tsuji S, Tomita T, Sugamoto K, Hideki Y, Hamada M (2013) Repeat-dose intravenous tranexamic acid further decreases blood loss in total knee arthroplasty. Int Orthop 37(3):441–445. doi:10.1007/s00264-013-1787-7
8. Irisson E, Hemon Y, Pauly V, Parratte S, Argenson JN, Kerbaul F (2012) Tranexamic acid reduces blood loss and financial cost in primary total hip and knee replacement surgery. Orthop Traumatol Surg Res 98(5):477–483. doi:10.1016/j.otsr.2012.05.002
9. Henry DA, Carless PA, Moxey AJ, O'Connell D, Stokes BJ, Fergusson DA, Ker K (2011) Anti-fibrinolytic use for minimising perioperative allogeneic blood transfusion. Cochrane Database Syst Rev 1:CD001886. doi:10.1002/14651858.CD001886.pub3
10. Wang M, Zheng XF, Jiang LS (2015) Efficacy and safety of antifibrinolytic agents in reducing perioperative blood loss and transfusion requirements in scoliosis surgery: a systematic review and meta-analysis. PLoS One 10(9):e0137886. doi:10.1371/journal.pone.0137886
11. Eubanks JD (2010) Antifibrinolytics in major orthopaedic surgery. J Am Acad Orthop Surg 18(3):132–138
12. Martin K, Knorr J, Breuer T, Gertler R, Macguill M, Lange R, Tassani P, Wiesner G (2011) Seizures after open heart surgery: comparison of epsilon-aminocaproic acid and tranexamic acid. J Cardiothorac Vasc Anesth 25(1):20–25. doi:10.1053/j.jvca.2010.10.007
13. Ipema HJ, Tanzi MG (2012) Use of topical tranexamic acid or aminocaproic acid to prevent bleeding after major surgical procedures. Ann Pharmacother 46(1):97–107. doi:10.1345/aph.1Q383
14. Tan J, Chen H, Liu Q, Chen C, Huang W (2013) A meta-analysis of the effectiveness and safety of using tranexamic acid in primary unilateral total knee arthroplasty. J Surg Res 184(2):880–887. doi:10.1016/j.jss.2013.03.099
15. Camarasa MA, Olle G, Serra-Prat M, Martin A, Sanchez M, Ricos P, Perez A, Opisso L (2006) Efficacy of aminocaproic, tranexamic acids in the control of bleeding during total knee replacement: a randomized clinical trial. Br J Anaesth 96(5):576–582. doi:10.1093/bja/ael057
16. Harley BJ, Beaupre LA, Jones CA, Cinats JG, Guenther CR (2002) The effect of epsilon aminocaproic acid on blood loss in patients who undergo primary total hip replacement: a pilot study. Can J Surg 45(3):185–190
17. Ray M, Hatcher S, Whitehouse SL, Crawford S, Crawford R (2005) Aprotinin and epsilon aminocaproic acid are effective in reducing blood loss after primary total hip arthroplasty—a prospective randomized double-blind placebo-controlled study. J Thromb Haemost 3(7):1421–1427. doi:10.1111/j.1538-7836.2005.01457.x
18. Tuttle JR, Ritterman SA, Cassidy DB, Anazonwu WA, Froehlich JA, Rubin LE (2014) Cost benefit analysis of topical tranexamic acid in primary total hip and knee arthroplasty. J Arthroplasty 29(8):1512–1515. doi:10.1016/j.arth.2014.01.031
19. Breda JR, Gurian DB, Breda AS, Meneghine A, Freitas AC, Matos LL, Abreu LC, Pires AC (2009) Topical use of antifibrinolytic agent to reduce postoperative bleeding after coronary artery bypass surgery. Rev Bras Cir Cardiovasc 24(3):341–345
20. Wang H, Shen B, Zeng Y (2015) Blood loss and transfusion after topical tranexamic acid administration in primary total knee arthroplasty. Orthopedics 38(11):e1007–1016. doi:10.3928/01477447-20151020-10
21. Martin JG, Cassatt KB, Kincaid-Cinnamon KA, Westendorf DS, Garton AS, Lemke JH (2014) Topical administration of tranexamic acid in primary total hip and total knee arthroplasty. J Arthroplasty 29(5):889–894. doi:10.1016/j.arth.2013.10.005
22. Abul-Azm A, Abdullah KM (2006) Effect of topical tranexamic acid in open heart surgery. Eur J Anaesthesiol 23(5):380–384. doi:10.1017/S0265021505001894
23. Krohn CD, Sorensen R, Lange JE, Riise R, Bjornsen S, Brosstad F (2003) Tranexamic acid given into the wound reduces postoperative blood loss by half in major orthopaedic surgery. Eur J Surg Suppl 588:57–61
24. Lemay E, Guay J, Cote C, Roy A (2004) Tranexamic acid reduces the need for allogenic red blood cell transfusions in patients undergoing total hip replacement. Can J Anaesth 51(1):31–37. doi:10.1007/BF03018543
25. So-Osman C, Nelissen R, Brand R, Faber F, Slaa RT, Stiggelbout A, Brand A (2013) The impact of a restrictive transfusion trigger on post-operative complication rate and well-being following elective orthopaedic surgery: a post-hoc analysis of a randomised study. Blood Transfus 11(2):289–295. doi:10.2450/2013.0172-12
26. Nadler SB, Hidalgo JH, Bloch T (1962) Prediction of blood volume in normal human adults. Surgery 51(2):224–232
27. Johansson T, Lisander B, Ivarsson I (1999) Mild hypothermia does not increase blood loss during total hip arthroplasty. Acta Anaesthesiol Scand 43(10):1005–1010
28. Kagoma YK, Crowther MA, Douketis J, Bhandari M, Eikelboom J, Lim W (2009) Use of antifibrinolytic therapy to reduce transfusion in patients undergoing orthopedic surgery: a systematic review of randomized trials. Thromb Res 123(5):687–696. doi:10.1016/j.thromres.2008.09.015
29. Ortmann E, Besser MW, Klein AA (2013) Antifibrinolytic agents in current anaesthetic practice. Br J Anaesth 111(4):549–563. doi:10.1093/bja/aet154